Thrombogenicity and early vascular healing response in metallic biodegradable polymer-based and fully bioabsorbable drug-eluting stents

T Koppara, Q Cheng, K Yahagi, H Mori… - Circulation …, 2015 - Am Heart Assoc
Background—Acute thrombogenicity and re-endothelialization represent clinically relevant
end points pertaining to the safety of coronary stents, which have not been compared among …

Hybrid ABSORB bioresorbable vascular scaffold and drug eluting stent or hybrid BVS–DES percutaneous coronary intervention: method and rationale for hybrid …

KL Yew - International Journal of Cardiology, 2015 - internationaljournalofcardiology.com
A 46-year-old man with type II diabetes mellitus presented with inferior ST segment
elevation myocardial infarction to the emergency department. He was thrombolyzed …

Further elucidation on “Hybrid ABSORB bioresorbable vascular scaffold and drug eluting stent or hybrid BVS–DES percutaneous coronary intervention: Method and …

KL Yew - International Journal of Cardiology, 2015 - internationaljournalofcardiology.com
It is heartening to note that there is viewership and interest in the article “Hybrid ABSORB
Bioresorbable vascular scaffold and drug eluting stent or hybrid BVS–DES percutaneous …

[PDF][PDF] Coronary Interventions

PBPE Stent - 2014 - academia.edu
Background—Biodegradable polymers for release of antiproliferative drugs from drug-
eluting stents aim to improve vascular healing. We assessed noninferiority of a novel …